The use of active mechanical circulatory support is growing rapidly around the world. The hope is that these systems will improve survival after the most severe form of acute heart failure, cardiogenic shock. A recent clinical trial led by heart specialist Professor Holger Thiele has shown that extracorporeal life support (ECLS) does not reduce 30-day mortality after cardiogenic shock. The finding is likely to influence future guidelines. The trial was recently presented at the annual congress of the European Society of Cardiology and published alongside an additional meta-analysis in the two most renowned medical journals, "The Lancet" and the "New England Journal of Medicine".

https://www.miragenews.com/despite-ecls-cardiogenic-shock-death-rates-1074757/

#miragenews